Advanced search
Publication Cover
International Journal of Neuroscience Volume 119, 2009 - Issue 12
Submit an article Journal homepage
542
Views
82
CrossRef citations to date
0
Altmetric
Research Article

QUETIAPINE IMPROVES VISUAL HALLUCINATIONS IN PARKINSON DISEASE BUT NOT THROUGH NORMALIZATION OF SLEEP ARCHITECTURE: RESULTS FROM A DOUBLE-BLIND CLINICAL-POLYSOMNOGRAPHY STUDY

HUBERT H. FERNANDEZ Department of Neurology, College of Medicine University of Florida, USACorrespondence[email protected]
,
MICHAEL S. OKUN Department of Neurology, College of Medicine University of Florida, USA
,
RAMON L. RODRIGUEZ Department of Neurology, College of Medicine University of Florida, USA
,
IRENE A. MALATY Department of Neurology, College of Medicine University of Florida, USA
,
JANET ROMRELL Department of Neurology, College of Medicine University of Florida, USA
,
ANQI SUN Department of Epidemiology and Health Policy Research, University of Florida, USA
,
SAMUEL S. WU Department of Epidemiology and Health Policy Research, University of Florida, USA
,
SANDEEP PILLARISETTY Department of Neurology, College of Medicine University of Florida, USA
,
ANAND NYATHAPPA Department of Neurology, College of Medicine University of Florida, USA
&
STEPHAN EISENSCHENK Department of Neurology, College of Medicine University of Florida, USA
 show all
Pages 2196-2205 | Received 04 Jul 2009, Published online: 16 Nov 2009

REFERENCES

  • Arnulf, I., Knofal, E., Merino-Andreu, M., Houeto, J. L., Mesnage, V., Welter, M. L., . (2002). Parkinson's disease and sleepiness: An integral part of PD. Neurology, 58, 1019–1024.
  • Comella, C. L., Tanner, C. M., & Ristanovic, R. K. (1993). Polysomnographic sleep measures in Parkinson's disease patients with treatment-induced hallucinations. Annals of Neurology, 34, 710–714.
  • Fernandez, H. H., Aarsland, D., Fénelon, G., Friedman, J. H., Marsh, L., Tröster, A. I., . (2008). Scales to assess psychosis in Parkinson's disease: Critique and recommendations. Movement Disorders, 23(4), 484–500.
  • Fernandez, H. H., Trieschmann, M. E., Burke, M. A., Jacques, C., & Friedman, J. H. (2003). Long-term quetiapine use for drug-induced psychosis among Parkinsonian patients. Movement Disorders, 18(5), 510–514.
  • Friedman, J. H., & Fernandez, H. H. (2002). Atypical antipsychotics in Parkinson sensitive populations. Journal of Geriatric Psychiatry and Neurology, 15(3), 156–570.
  • Goetz, C. G., & Stebbins, G. T. (1995). Mortality and hallucinations in nursing home patient with advanced Parkinson's disease. Neurology, 45, 669–671.
  • Juri, C., Chana, P., Tapia, J., Kuntsmann, C., & Parrao, T. (2005). Quetiapine for insomnia in Parkinson disease: Results from an open-label trial. Clinical Neuropharmacology, 28, 185–187.
  • Nomura, T., Inoue, Y., Mitani, H., Kawahara, R., Miyake, M., & Nakashima, K. (2003). Visual hallucinations as REM sleep behavior disorders in patients with Parkinson's disease. Movement Disorders, 18, 812–817.
  • Ondo, W. G., Tintner, R., Voung, K. D., Lai, D., & Ringholz, G. (2005). Double-blind, placebo-controlled, unforced titration parallel trial of quetiapine for dopaminergic-induced hallucinations in Parkinson's disease. Movement Disorders, 20(8), 958–963.
  • Pappert, E. J., Goetz, C. G., Niederman, F., Raman, R., & Leurgans, S. (1999). Hallucinations, sleep fragmentation, and altered dream phenomena in Parkinson's Disease. Movement Disorders, 14(1), 117–121.
  • Rabey, J. M., Prokhorov, T., Miniovich, A., Dobronevsky, E., & Klein, C. (2007). The effect of quetiapine in psychotic Parkinson's disease patients: A double-blind labeled study of three months duration. Movement Disorders, 22(3), 313–318.
  • The French Clozapine Parkinson Study Group. (1999). Clozapine in drug-induced psychosis in Parkinson's disease. Lancet, 353(9169), 2041–2042.
  • The Parkinson Study Group. (1999). Low-dose clozapine for the treatment of drug-induced psychosis in Parkinson's disease. The New England Journal of Medicine, 340(10), 757–763.
  • Zahodne, L., & Fernandez, H. H. (2008). Pathophysiology and treatment of psychosis in Parkinson's disease: A review. Drugs and Aging, 25(8), 665–682.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.